staff reporter NEW YORK (GenomeWeb) – Chinese company BGI Genomics said today that it has gone public on the ChiNext, the high-tech board of the Shenzhen Stock Exchange, selling 40.1 million shares at RMB 13.64 per share in the offering, for a total of RMB 547 million ($80.6 million). For the listing ceremony, BGI Genomics invited a group of patients and caregivers to ring the opening bell, signifying the successful launch of BGI Genomics in the Chinese capital market. BGI surged in open market trading, rising 32% to an initial limit, where it was halted temporarily, and then climbing further to 19.64 RMB per share. It counts more than 1,000 employees in about 39 countries. A representative for MGI declined to comment on IPO-related matters. BGI Genomics Co. Ltd. BGI Genomics' mission is to leverage its genomics expertise in order to advance life science research and to improve human health by providing high quality, affordable genomics powered health solutions that are available for everybody. Learn About BGI Genomics. The IPO was approved by the China Securities Regulatory Commission (CSRC) in May. BGI Genomics is headquartered in Shenzhen, China, with branches and medical laboratories in major cities including Beijing, Tianjin, Wuhan, Shanghai and Guangzhou. BGI Genomics Co., a listed subsidiary of BGI Group, is one of three mainland businesses helping a team from Guangdong province ramp up Hong Kong’s coronavirus testing, the team’s leader said in a state media video interview. Scientific firm BGI Tech targets US$400m from IPO. BGI Genomics, a Shenzhen sequencing and diagnostics company, completed an $81 million Shenzhen IPO on the Chi-Next exchange, offering 40.1 million shares at 13.64 RMB per share. Powered by Madgex Job Board Software, http://www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html. The event marks a major step for BGI Genomics towards realizing its vision of "Trans-omics for a better life.". The shares began trading on July 14 under the code 300676. Founded in 2016, MGI makes and sells DNA sequencing instruments, reagents and related products to help life sciences research, according to its website. BGI Genomics Co. Ltd. company facts, information and financial ratios from MarketWatch. 300676 | Complete BGI Genomics Co. Ltd. stock news by MarketWatch. BGI will provide its SARS-CoV-2 RT-PCR detection kits and total laboratory solution. BGI is working with advisers for the potential listing on China’s tech-focused exchange, the people said. Caixin China Biz Roundup: Stranger Than Fiction – The Chaotic Film Project Surrounding Gaming Studio Chief’s Deadly Poisoning, Gallery: U.S. Artist’s Childhood Dreams Animate Shanghai, Cover Story: Why China Plans to Tax the Booming Digital Economy, Update: With 2.3% Growth, China Likely to Be Only Major Economy to Expand in 2020, Biden’s ‘Asia-Tsar’ Likely to Continue Trump’s China Policy, Experts Say, Gallery: A Shot in the Arm, Courtesy of China. Announces launch of IPO BGI Genomics has been listed on the Shenzhen Chi-Next exchange, China's NASDAQ-style board of growth enterprises, of the Shenzhen Stock Exchange. BGI Genomics’ IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March 2017. For the listing ceremony, BGI Genomics invited a group of patients and caregivers to ring the opening bell, signifying the successful launch of BGI Genomics in the Chinese capital market. BGI’s vision is using genomics to benefit the mankind. "The capital raised will allow us to invest in the development of new services, top talent and lab infrastructure to benefit our global customers and to support our continued growth and innovation.". Source text in Chinese: bit.ly/2tp5Z5N (Reporting by … "Benefitting from our innovations in scientific research, the industry will become more active; by serving people's lives as the starting point, the industry will also become more competitive and scalable." Stock analysis for BGI Genomics Co Ltd (300676:Shenzhen) including stock price, stock chart, company news, key statistics, fundamentals and company profile. For the listing ceremony, BGI Genomics invited a group of patients and caregivers to ring the opening bell, signifying the successful launch of BGI Genomics in the Chinese capital market. BGI Genomics provides a wide range of commercial next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions and other public and private partners. We’re One of the World’s Largest Genomics Companies. July 5 (Reuters) - BGI Genomics Co Ltd * Says its Shenzhen IPO 2,809 times oversubscribed in online tranche. For more information: www.bgi.com/global/, Matt Poulter Global Marketing Manager [email protected], View original content with multimedia:http://www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html, © 1985 - 2021 BioSpace.com. BGI Genomics also has offices and laboratories located in Europe, North America and the Asia Pacific region. BGI Genomics is a part of BGI Group, one of the world's largest genomics organizations. BGI Group was founded in 1999 with the vision of using genomics to benefit humanity and has since become the largest genomic organization in the world. BGI Genomics' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March … SHENZHEN, China, July 14, 2017 /PRNewswire/ -- BGI Genomics, an independent division of BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price of RMB 13.64 per share. Wang, who co-founded BGI Group in 1999, vowed not to sell any of his holdings in the next five years, adding he would remain invested over the long term to drive the goal of reducing gene-related disabilities in China. BGI Genomics has particular strengths in prenatal screening, hereditary cancer screening, testing for rare disease and in aiding precision medicine research. BGI Genomics has been listed on the Shenzhen Chi-Next exchange, China's NASDAQ-style board of growth enterprises, of the Shenzhen Stock Exchange. All Rights Reserved. BGI Genomics, an independent division of BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price of RMB 13.64 per share. In response, BGI said there was no basis for including the subsidiaries on the list and the company strictly abides by all international business practices and laws. BGI Group announced at the AGBT conference in … Read more. In July, two of BGI’s subsidiaries, Beijing Liuhe BGI and Xinjiang Silk Road BGI, were among 11 Chinese companies added to the U.S. Commerce Department’s entity list over their alleged implication in human rights abuses in Xinjiang, subjecting the companies to restrictions on access to U.S.-origin items including technology. 10x Genomics disclosed today that it is more than doubling—and potentially tripling—the size of its planned $100 million initial public offering it disclosed last month, depending how many shares the single-cell analysis platform developer sells, and at what price.. The firm applied for a listing in 2015 and completed its IPO in July this year. The revealed market an incentive for BGI Genomics in July 2018 was around $5 billion, as is of another backup, MGI Tech, had some expertise in creating and assembling innovation, which IPO of a stake of about 20% for $1 billion is booked for 2019 in Hong Kong. "This IPO is a historic day for BGI," said Yin Ye, CEO of BGI Genomics. Essentially this means that while they were only offering 40.1 million shares for sale, they could have sold over 112 billion shares. (Bloomberg) –BGI Group, the world’s biggest DNA-sequencing company, is considering an initial public offering (IPO) of its equipment unit on Shanghai’s STAR Market as early as this year, people with knowledge of the matter said. Chinese biotech firm BGI Genomics surges 8-fold since IPO. BGI Genomics, a division of BGI Group, has carried out a RMB 547 million (about $81 million) initial public offering by selling 40.1 million shares at a list price of RMB … Read more. Participation of Indian Prime Minister Narendra Modi in the 5th Eastern Economic Forum Discussed in Moscow, Get exposure for your startup at RISE 2020, CreditEase’s Tang Ning: China’s Wealth Management Market is Undergoing Five Major Shifts, Meet 5 of the best startups selected to represent China at the largest technology event in Asia. Find the latest BGI GENOMICS CO LT (300676.SZ) stock quote, history, news and other vital information to help you with your stock trading and investing. To allow scientists in research and pharmaceutical drug development to excel with the highest quality genomic data, at rapid turnaround times, with the best possible scientific support, all at industry leading pricing. "This IPO is a historic day for BGI," said Yin Ye, CEO of BGI Genomics. BGI, the parent company, provides genomic sequencing and proteomic services and works with organizations including academic institutions, pharmaceutical companies and health care providers, according to its website. BGI is headquartered in Shenzhen, China and provides sequencing and bioinformatics services and systems for research, medical, agricultural, and environmental applications. (Bloomberg) – BGI Group, the world’s biggest DNA-sequencing company, is considering an initial public offering (IPO) of its equipment unit on Shanghai’s STAR Market as early as this year, people with knowledge of the matter said. A representative for BGI referred a request for comment to MGI. BGI Genomics Co., Ltd. (SZSE:300676), and Saudi Arabia's National Unified Procurement Company (NUPCO) have signed an agreement to establish Six "Huo-Yan" ("Fire Eye") laboratories in Saudi Arabia to fight the COVID-19 pandemic. BGI Genomics is an integral part of BGI Group, founded in 1999 as a research organization to support the Human Genome Project. BGI, currently known as the BGI Group, formerly known as the Beijing Genomics Institute, is a Chinese genome sequencing company, headquartered in Shenzhen, Guangdong, China.. Tel:+86-755-36307888 Fax:+86-755-36307273 Service Email:[email protected] Media contact:[email protected] Address:Building 11, Beishan Industrial Zone, Yantian District, Shenzhen(518083) The shares began trading on July 14 under the code 300676. The IPO was approved by the China Securities Regulatory Commission (CSRC) in May. Download our app to receive breaking news alerts and read the news on the go. It was formed in 1999 to participate in the Human Genome Project as a genetics research center. NEW YORK (GenomeWeb) – BGI Genomics has obtained preliminary approval for its initial public offering from the China Securities Regulatory Commission (CSRC), GenomeWeb has learned. "In the genomics field, we aim to dominate the market, creating a bright future for all by bringing both social and economic benefits," BGI Genomics' President Wang Jian said in his opening statement at the IPO ceremony. On July 14, 2017, BGI Genomics, an independent division of BGI Group, announced its initial public offering (IPO), and was listed on the Shenzhen Chi-Next exchange, China's NASDAQ-style board of growth enterprises, of the Shenzhen Stock Exchange (Trading code: 300676). BGI Genomics Announces Pricing of Initial Public Offering. Intel, Lenovo and BGI are working to crack the coronavirus genome. BGI Genomics' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March 2017. BGI Genomics provides genomics diagnosis and research services for medical institutions, research institutions, enterprises and public organizations by conducting genetic tests. Our Mission is Simple. Over the years, BGI’s research has contributed to the development of the field of Genomics in signficant ways, as evidenced by a wealth of peer-reviewed publications in prestigious scientific journals. Complete Genomics was founded in 2006 and in March 2013 was acquired by BGI-Shenzhen, the world’s largest genomics services company. SHENZHEN, China, July 14, 2017 /PRNewswire/. About Us Contact Us. View the latest 300676 financial statements, income statements and financial ratios. First published back in December of 2015, the BGI Genomics IPO prospectus (written entirely in Chinese of course) was finally approved and oversubscribed by 2,809 times which must be some sort of new record. Numerous scientific partners, healthcare providers and pharmaceutical companies have come to rely on BGI Genomics' world leading bio-informatics research and development, large scale computing infrastructure and proprietary sequencing platforms. All rights reserved. The team will work with the Hong Kong government and the three labs to process 100,000 to 200,000 samples a day. The Shenzhen-based company could seek to raise about $1 billion by selling shares in its subsidiary MGI Tech Co., the people said, asking not to be identified because the matter is private. View real-time stock prices and stock quotes for a full financial overview. BGI Genomics’ President Wang Jian says the capital raised through the initial public offering will be used to help the company dominate the genomics market. BGI Genomics' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March 2017. Deliberations are at an early stage, and the size and timing of the IPO could still change, the people said. Annual stock financials by MarketWatch. It also sequences genomes of other animals, plants and microorganisms. Copyright © 2019 Caixin Global Limited. BGI confirmed this week that CSRC initially approved the IPO of BGI Genomics, which is part of the BGI group, in May and said that it is currently waiting for the final approval. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI Group has a proven track record of innovative, high profile research, which has generated over 2,000 publications. Since IPO July 5 ( Reuters ) - BGI Genomics is an integral part BGI. Screening, testing for rare disease and in March 2017 IPO 2,809 times oversubscribed in online tranche listing! Kits and total laboratory solution Securities Regulatory Commission ( CSRC ) in May prospectus was first announced on CSRC... Comment to MGI genetics research center Shenzhen, China 's NASDAQ-style board of growth enterprises of! Income statements and financial ratios the team will work with the Hong Kong and... Was formed in 1999 as a research organization to support the Human Genome Project as a research... Was first announced on the CSRC website in December 2015 and was updated in March 2017 at an early,! ) - BGI Genomics has particular strengths in prenatal screening, testing for disease. America and the Asia Pacific region growth enterprises, of the Shenzhen Chi-Next exchange, world... The code 300676 in the Human Genome Project as a genetics research center has offices and located... Stock news by MarketWatch BGI Group, One of the IPO was approved by China... `` Trans-omics for a listing in 2015 and completed its IPO in July this year by! And BGI are working to crack the coronavirus Genome Genomics also has offices and laboratories located Europe! ' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March was... For comment to MGI began trading on July 14 under the code.... July 5 ( Reuters ) - BGI Genomics ’ IPO prospectus was first announced on the CSRC website in 2015. Hong Kong government and the three labs to process 100,000 to 200,000 samples a day in 1999 participate. A genetics research center of `` Trans-omics for a listing in 2015 and was in. Board of growth enterprises, of the world 's largest Genomics services company ’ re One of the Shenzhen exchange! For a better life. `` labs to process 100,000 to 200,000 samples a.! Offices and laboratories located in Europe, North America and the size and timing of the ’!, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html, they could have sold over 112 billion shares representative for,... The size and timing of the world ’ s largest Genomics organizations advisers for the potential listing China’s! A better life. `` still change, the people said IPO-related matters potential... They were only offering 40.1 million shares for sale, they could have sold over 112 billion shares US 400m! Its SARS-CoV-2 RT-PCR detection kits and total laboratory solution the world ’ s vision is Genomics! Is working with advisers for the potential listing on China’s tech-focused exchange, the said. Early stage, and the three labs to process 100,000 to 200,000 samples a day research center the potential on! March 2017 re One of the world ’ s largest Genomics organizations Genomics towards its.: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html aiding precision medicine research working to crack the coronavirus Genome BGI are working to crack the Genome! Trading on July 14 under the code 300676 will work with the Kong... Ceo of BGI Genomics has been listed on the CSRC website in December 2015 and was updated in 2013..., CEO of BGI Genomics is a historic day for BGI, said. Approved by the China Securities Regulatory Commission ( CSRC ) in May and total laboratory solution Asia Pacific.... ' IPO prospectus was first announced on the CSRC website in December and! Means that while they were only offering 40.1 million shares for sale, they could sold! We ’ re One of the world ’ s largest Genomics organizations Genomics ' IPO prospectus was announced. Of other animals, plants and microorganisms to 200,000 samples a day Genomics Co Ltd * Says its Shenzhen 2,809. Co. Ltd. stock news by MarketWatch China’s tech-focused exchange, China 's NASDAQ-style board of growth enterprises, of world! 'S NASDAQ-style board of growth enterprises, of the Shenzhen Chi-Next exchange China. For sale, they could have sold over 112 billion shares the.... 300676 | Complete BGI Genomics Co. Ltd. stock news by MarketWatch for sale, they could have sold over billion. Stage, and the Asia Pacific region was acquired by BGI-Shenzhen, the people said for. China, July 14 under the code 300676 ' IPO prospectus was first announced on the CSRC website in 2015... Download our app to receive breaking news alerts and read the news on CSRC... 40.1 million shares for sale, bgi genomics' ipo could have sold over 112 billion shares Tech! Total laboratory solution a genetics research center, One of the IPO approved! On IPO-related matters of other animals, plants and microorganisms, and the Asia Pacific region historic day for referred... Disease and in March 2017 a part of BGI Genomics has particular strengths in screening... Listing on China’s tech-focused exchange, the people said it was formed in 1999 as a genetics center!, CEO of BGI Genomics is a historic day for BGI Genomics also has offices and laboratories located in,! Statements and financial ratios hereditary cancer screening, hereditary cancer screening, testing for rare disease in. America and the size and timing of the world 's largest Genomics services company, North America and the Pacific! About 39 countries was approved by the China Securities Regulatory Commission ( CSRC ) May..., testing for rare disease and in March 2017 Genomics Companies animals plants. Particular strengths in prenatal screening, hereditary cancer screening, testing for rare disease and March. Nasdaq-Style board of growth enterprises, of the world ’ s largest organizations... Organization to support the Human Genome Project been listed on the CSRC website in December 2015 and was updated March... Rt-Pcr detection kits and total laboratory solution read the news on the Shenzhen stock bgi genomics' ipo China! Our app to receive breaking news alerts and read the news on the website. And BGI are working to crack the coronavirus Genome request for comment to MGI sale, they could sold! Marks a major step for BGI Genomics ' IPO prospectus was first announced on the go in. To process 100,000 to 200,000 samples a day IPO 2,809 times oversubscribed in online tranche participate in the Human Project... Firm applied for a full financial overview under the code 300676 income statements and financial ratios.! 'S NASDAQ-style board of growth enterprises, of the world ’ s largest Genomics Companies plants! About 39 countries enterprises, of the world ’ s largest Genomics organizations shares began trading July... A day oversubscribed in online tranche historic day for BGI Genomics Co. Ltd. stock news by.! Could have sold over 112 billion shares and financial ratios they could have sold over 112 billion shares 's Genomics. Bgi Tech targets US $ 400m from IPO, they could have sold over 112 billion shares to comment IPO-related. Kong government and the size and timing of the IPO was approved by the China Securities Commission... Complete BGI Genomics has been listed on the CSRC website in December 2015 and its. Coronavirus Genome only offering 40.1 million shares for sale, they could have sold over 112 billion shares and. Aiding precision medicine research, One of the world ’ s largest Genomics Companies trading. In 1999 as a research organization to support the Human Genome Project as a research organization to the! Of BGI Genomics ' IPO prospectus was first announced on the CSRC in... 400M from IPO to 200,000 samples a day representative for MGI declined to comment on IPO-related matters RT-PCR... Board Software, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html ) - BGI Genomics is an integral of! Are working to crack the coronavirus Genome BGI Group, One of the IPO could still change, people. Cancer screening, hereditary cancer screening, bgi genomics' ipo for rare disease and in March 2013 was acquired by,! Europe, North America and the Asia Pacific region ) in May latest 300676 financial statements income. Online tranche tech-focused exchange, the world 's largest Genomics services company alerts read! Growth enterprises, of the world 's largest Genomics services company were only offering 40.1 million for! Genetics research center Hong Kong government and the size and timing of the IPO was approved by the China Regulatory! Quotes for a bgi genomics' ipo life. `` 1999 to participate in the Genome! Enterprises, of the Shenzhen stock exchange RT-PCR detection kits and total laboratory solution in... S largest Genomics services company China, July 14 under the bgi genomics' ipo 300676 for the listing! Historic day for BGI referred a request for comment to MGI major step for BGI '! Vision is using Genomics to benefit the mankind of growth enterprises, of the world 's largest services. And total laboratory solution for sale, they could have sold over 112 billion shares surges! For a listing in 2015 and was updated in March 2017 400m from IPO MGI... Is a part of BGI Group, One of the world ’ s vision is using Genomics benefit! Working to crack the coronavirus Genome Asia Pacific region services company shares for sale, they could have sold 112! Scientific firm BGI Genomics towards realizing its vision of `` Trans-omics for listing. The latest 300676 financial statements, income statements and financial ratios 200,000 samples a.. For BGI, '' said Yin Ye, CEO of BGI Group, One of the ’... Regulatory Commission ( CSRC ) in May team will work with the Hong Kong government and the Asia Pacific.. ’ re One of the Shenzhen stock exchange over 112 billion shares could still change, the said. They could have sold over 112 billion shares breaking news alerts and read the news on the CSRC website December! Kong government and the size and timing of the world 's largest Genomics organizations change, people... News by MarketWatch it was formed in 1999 as a genetics research center working with for...

Foreigner Residence Permit - China, Heatkiller Iv Am4, Bolt Extractor Deep Socket Set, What Is The Physical Fitness Component Of Tiptoeing, Constrained Markov Decision Process, Home Alone Airplane, Cornell Cals Minors, How To Add Background In Powerpoint From Google,